Hops compound for septic shock treatment
Part of Infections, Lungs & breathing clinical trials.
This trial tests whether a natural compound from hops (xanthohumol) can help people with severe septic shock. It's given early, within the first day, alongside standard intensive care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have septic shock that started less than a day ago
- You need to be on a breathing machine with very low oxygen levels (PaO2/FiO2 under 150)
- A bacterial infection must be confirmed
- Your blood levels of procalcitonin must be above 5 and interleukin-6 above 100
- You must not be allergic to hops or anything made from hops
- Your blood pressure must be unstable, requiring IV medications to support it
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new approach to treating septic shock, a life-threatening condition where infection causes dangerously low blood pressure. It aims to see if a different way of managing fluids and medications can improve recovery compared to standard care.
This trial tests a special fluid management strategy for people in septic shock—a serious infection that causes very low blood pressure. It aims to improve blood flow to organs and help you recover.
This study tests a medication called anisodamine to see if it can improve blood flow in tiny blood vessels under the tongue in people with septic shock. This might help their organs work better and make them recover faster.
This study tests a blood-filtering treatment for people with septic shock, a severe infection that causes very low blood pressure. The treatment aims to remove harmful substances from the blood to help patients recover.
This study looks at whether a metabolite (nutrient) supplement can help the body’s cells work better when someone is in septic shock. It is done in the ICU, and it may benefit people with sepsis who still have poor circulation and high lactate levels despite standard treatment.
This trial tests whether an herbal medicine called Shenfu Injection can improve blood flow regulation in patients with septic shock. It aims to help stabilize blood pressure and might reduce the need for vasopressors.
Hear when a new Septic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.